|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 11/05/15 Chemours Co 10-Q 9/30/15 106:9.6M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 741K
2: EX-10.25 Material Contract -- exhibit1025 HTML 112K
7: EX-95 Mine-Safety Disclosure HTML 36K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 37K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 36K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 31K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 32K
71: R1 Document and Entity Information HTML 49K
57: R2 Interim Combined Statements of Operations HTML 94K
(Unaudited)
69: R3 Interim Combined Statements of Operations HTML 33K
(Unaudited) Interim Combined Statements of
Operations (Unaudited) (Parenthetical)
75: R4 Interim Consolidated Statements of Comprehensive HTML 144K
(Loss) Income (Unaudited)
96: R5 Interim Combined Balance Sheets HTML 129K
60: R6 Interim Consolidated Balance Sheet (Parenthetical) HTML 38K
68: R7 Interim Consolidated Statements of Stockholders' HTML 82K
Equity (Unaudited)
51: R8 Interim Consolidated Statements of Stockholders' HTML 33K
Equity (Unaudited) (Parenthetical)
42: R9 Interim Combined Statements of Cash Flows HTML 108K
(Unaudited)
98: R10 Interim Combined Statements of Cash Flows HTML 32K
(Unaudited) (Parenthetical)
77: R11 Background and Description of the Business HTML 43K
76: R12 Basis of Presentation HTML 43K
83: R13 Summary of Significant Accounting Policies HTML 54K
84: R14 Relationship with DuPont and Related Entities HTML 77K
81: R15 Research and Development Expense HTML 38K
85: R16 Employee Separation and Asset Related Charges, Net HTML 133K
70: R17 Other Income, Net HTML 55K
72: R18 Income Taxes HTML 37K
79: R19 Accounts and Notes Receivable - Trade, Net HTML 52K
106: R20 Earnings Per Share of Common Stock HTML 64K
92: R21 Inventories HTML 45K
64: R22 Property, Plant, and Equipment HTML 38K
78: R23 Goodwill and Intangible Assets, Net HTML 90K
66: R24 Other Assets HTML 46K
33: R25 Debt HTML 58K
93: R26 Commitments and Contingent Liabilities HTML 60K
102: R27 Financial Instruments HTML 62K
46: R28 Long-Term Employee Benefits HTML 122K
45: R29 Segment Information HTML 174K
49: R30 Stock-based Compensation HTML 83K
50: R31 Summary of Significant Accounting Policies HTML 66K
(Policies)
52: R32 Relationship with DuPont and Related Entities HTML 66K
(Tables)
22: R33 Employee Separation and Asset Related Charges, Net HTML 124K
(Tables)
90: R34 Other Income, Net (Tables) HTML 54K
62: R35 Accounts and Notes Receivable - Trade, Net HTML 46K
(Tables)
65: R36 Earnings Per Share of Common Stock (Tables) HTML 65K
37: R37 Inventories (Tables) HTML 42K
105: R38 Goodwill and Intangible Assets, Net (Tables) HTML 79K
14: R39 Other Assets (Tables) HTML 46K
54: R40 Debt (Tables) HTML 47K
95: R41 Financial Instruments (Tables) HTML 63K
35: R42 Long-Term Employee Benefits (Tables) HTML 120K
44: R43 Segment Information (Tables) HTML 166K
48: R44 Stock-based Compensation (Tables) HTML 76K
58: R45 Background and Description of the Business HTML 49K
(Narrative) (Details)
21: R46 Basis of Presentation (Details) HTML 32K
41: R47 Summary of Significant Accounting Policies Summary HTML 32K
of Significant Accounting Policies (Details)
16: R48 Research and Development Expense (Details) HTML 39K
94: R49 Relationship with DuPont and Related Entities HTML 43K
(Related Party Purchases and Sales) (Details)
34: R50 Relationship with DuPont and Related Entities HTML 41K
(Leveraged Services and Corporate Costs) (Details)
91: R51 Relationship with DuPont and Related Entities HTML 34K
(Details)
38: R52 Employee Separation and Asset Related Charges, Net HTML 43K
Employee Separation and Assets Related Charges,
Net (Charges) (Details)
55: R53 Employee Separation and Asset Related Charges, Net HTML 84K
Employee Separation and Asset Related Charges, Net
(Narrative) (Details)
15: R54 Employee Separation and Asset Related Charges, Net HTML 89K
(Segment Earnings) (Details)
19: R55 Employee Separation and Asset Related Charges, Net HTML 66K
(Restructuring Program schedule) (Details)
47: R56 Other Income, Net (Schedule of Other Income) HTML 51K
(Details)
26: R57 Income Taxes (Details) HTML 37K
99: R58 Accounts and Notes Receivable - Trade, Net HTML 45K
(Schedule of Accounts and Notes Receivable)
(Details)
61: R59 Earnings Per Share of Common Stock (Earnings per HTML 49K
Share Calculation) (Details)
82: R60 Accounts and Notes Receivable - Trade, Net HTML 51K
(Narrative) (Details)
40: R61 Earnings Per Share of Common Stock (Antidilutive HTML 34K
Shares Excluded from Computation of Earnings per
Share) (Details)
43: R62 Inventories (Details) HTML 48K
89: R63 Property, Plant, and Equipment Property, Plant and HTML 38K
Equipment (Details)
86: R64 Goodwill and Intangible Assets, Net Goodwill and HTML 52K
Intangible Assets, Net (Schedule of Goodwill)
(Details)
63: R65 Goodwill and Intangible Assets, Net (Narrative) HTML 56K
(Details)
88: R66 Goodwill and Intangible Assets, Net (Schedule of HTML 48K
Other Intangible Assets) (Details)
39: R67 Other Assets (Details) HTML 52K
67: R68 Debt (Components of Long-Term Debt) (Details) HTML 67K
101: R69 Debt (Senior Secured Credit Facilities) (Details) HTML 72K
18: R70 Debt (Senior Unsecured Notes) (Details) HTML 57K
32: R71 Debt (Maturities and Fair Value) (Details) HTML 70K
56: R72 Commitments and Contingent Liabilities HTML 32K
(Guarantees) (Details)
24: R73 Commitments and Contingent Liabilities HTML 84K
(Litigation) (Narrative) (Details)
104: R74 Commitments and Contingent Liabilities HTML 51K
(Environmental) (Narrative) (Details)
36: R75 Financial Instruments (Details) HTML 57K
27: R76 Financial Instruments (Schedule of the Fair Value HTML 47K
of Derivative Instruments) (Details)
31: R77 Long Term Employee Benefits Defined Benefit Plans HTML 38K
(Narrative) (Details)
20: R78 Long-Term Employee Benefits (Mulitemployer Plan) HTML 38K
(Details)
23: R79 Long-Term Employee Benefits (Single and Multiple HTML 63K
Employer Plans) (Details)
73: R80 Long-Term Employee Benefits (Schedules of Net HTML 48K
Periodic Benefit Cost) (Details)
29: R81 Long-Term Employee Benefits (Assumptions) HTML 39K
(Details)
100: R82 Long-Term Employee Benefits (Plan Assets) HTML 81K
(Details)
53: R83 Long-Term Employee Benefits (Cash Flow) (Details) HTML 58K
80: R84 Segment Information (Narrative) (Details) HTML 31K
87: R85 Stock-based Compensation (Details) HTML 62K
28: R86 Segment Information (Schedule of Segment HTML 56K
Information) (Details)
30: R87 Stock-based Compensation (Stock Option HTML 44K
Assumptions) (Details)
97: R88 Segment Information (Reconciliation to HTML 57K
Consolidated Income Statements) (Details)
25: R89 Stock-based Compensation (Stock Option Activity) HTML 77K
(Details)
74: R90 Stock-based Compensation (Restricted Stock Units) HTML 61K
(Details)
103: XML IDEA XML File -- Filing Summary XML 201K
17: EXCEL IDEA Workbook of Financial Reports XLSX 114K
8: EX-101.INS XBRL Instance -- cc-20150930 XML 2.81M
10: EX-101.CAL XBRL Calculations -- cc-20150930_cal XML 307K
11: EX-101.DEF XBRL Definitions -- cc-20150930_def XML 839K
12: EX-101.LAB XBRL Labels -- cc-20150930_lab XML 1.87M
13: EX-101.PRE XBRL Presentations -- cc-20150930_pre XML 1.18M
9: EX-101.SCH XBRL Schema -- cc-20150930 XSD 215K
59: ZIP XBRL Zipped Folder -- 0001627223-15-000050-xbrl Zip 280K
| Exhibit |
1. | I have reviewed this report on Form 10-Q of The Chemours Company; |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared; |
b) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
c) | Disclosed in this report any change in the
registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based
on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b) | Any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: | |
By: | /s/ Mark
P. Vergnano |
President and Chief Executive Officer | |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/5/15 | 8-K | ||
| For Period end: | 9/30/15 | 4 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/27/24 Chemours Co. 10-K 12/31/23 200:50M Donnelley … Solutions/FA 2/10/23 Chemours Co. 10-K 12/31/22 185:39M Donnelley … Solutions/FA 2/11/22 Chemours Co. 10-K 12/31/21 185:36M ActiveDisclosure/FA 2/12/21 Chemours Co. 10-K 12/31/20 182:38M ActiveDisclosure/FA |